Application 012827

Type
NDA
Sponsor
CASPER PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ROBINULGLYCOPYRROLATETABLET;ORAL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002ROBINUL FORTEGLYCOPYRROLATETABLET;ORAL2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16571-743GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
16571-743GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
16571-744GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
16571-744GlycopyrrolateGlycopyrrolateRising Pharma Holdings, Inc.NDA AUTHORIZED GENERICCurrent
59630-200RobinulGlycopyrrolateShionogi Inc.NDACurrent
59630-205Robinul ForteGlycopyrrolateShionogi Inc.NDACurrent
68788-8279GlycopyrrolateGlycopyrrolatePreferred Pharmaceuticals Inc.NDA AUTHORIZED GENERICCurrent
70199-007RobinulGlycopyrrolateCasper Pharma LLCNDACurrent
70199-007RobinulGlycopyrrolateCasper Pharma LLCNDACurrent
70199-008Robinul ForteGlycopyrrolateCasper Pharma LLCNDACurrent
70199-008Robinul ForteGlycopyrrolateCasper Pharma LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72198SUPPL2022-09-30
72168SUPPL2022-09-28
48242SUPPL2017-05-05
40683SUPPL2009-09-14
40682SUPPL2009-09-14
40681SUPPL2009-09-14
40680SUPPL2009-09-14
40679SUPPL2009-09-14
40678SUPPL2009-09-14
20038SUPPL2009-09-14
20037SUPPL2009-09-14
20036SUPPL2009-09-14
20035SUPPL2009-09-14
20034SUPPL2009-09-14
344SUPPL2003-08-06